These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28494191)

  • 1. Biomarker for early renal microvascular and diabetic kidney diseases.
    Futrakul N; Futrakul P
    Ren Fail; 2017 Nov; 39(1):505-511. PubMed ID: 28494191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes.
    Yang YS; Peng CH; Lin CK; Wang CP; Huang CN
    Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that even "normal" albuminuria may denote incipient GFR reduction in patients with type 2 diabetes mellitus.
    Kravaritou M; Thanopoulou A; Karamanos B; Kofinis A; Noutsou M; Spanou E; Varsou A; Archimandritis A
    Diabetes Res Clin Pract; 2009 Sep; 85(3):317-21. PubMed ID: 19596469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
    Babaliche P; Nadpara RA; Maldar A
    J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.
    Jeon YL; Kim MH; Lee WI; Kang SY
    Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
    Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.
    Chauhan K; Verghese DA; Rao V; Chan L; Parikh CR; Coca SG; Nadkarni GN
    Kidney Int; 2019 Feb; 95(2):439-446. PubMed ID: 30591223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
    Cohen MP; Lautenslager GT; Shearman CW
    Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B; Tekce H; Aktas G; Sit M
    Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.